For instance, NOTCH4, a highly heterogeneous gene and also the target for immune checkpoint inhibitor therapy39, was revealed to be associated with multiple IMDs (celiac disease, Graves’ disease, HPT, psoriasis and scleroderma). The gene discussed is NOTCH4; the disease is scleroderma.